JAVIER
PUENTE VÁZQUEZ
Profesor asociado de Ciencias de la Salud
Harvard Medical School
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Harvard Medical School (5)
2023
-
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
Journal of Clinical Oncology, Vol. 41, Núm. 18, pp. 3339-3351
2022
-
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
The Lancet Oncology, Vol. 23, Núm. 3, pp. 362-373
-
Recent therapeutic advances in urothelial carcinoma: A paradigm shift in disease management
Critical Reviews in Oncology/Hematology, Vol. 174
2015
-
New advances in genitourinary cancer: evidence gathered in 2014
Cancer and Metastasis Reviews, Vol. 34, Núm. 3, pp. 443-464
2013
-
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma
Annals of Oncology, Vol. 24, Núm. 9, pp. 2409-2414